Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
暂无分享，去创建一个
V. Demarco | B. Chandrasekar | Guanghong Jia | M. Hayden | J. Habibi | J. Padilla | L. Martinez‐Lemus | N. Das | Francisco I. Ramirez-Perez | Camila Manrique-Acevedo | A. Carpenter | A. Aroor | R. Nistala | Cornel Duta | E. Mayoux | V. DeMarco